Top Breaking News | More News | Featured Stories | News By Subject | Event News | Investor News | News Archive | Search News
Get Our FREE
Industry eNewsletter
email:    

Investor News

Clinical Development News
Pre-Clinical
IND
Phase I - Safety
Phase II - Safety and Efficacy
Phase III - Controlled Safety and Efficacy
BLA/NDA/ANDA
PDUFA
Approvable Letters
Approval and Marketing Clearance
Post-Approval
Discontinued
Recalls and Warnings

Deals & Dollars News
Alliances
Earnings Reports
Financial
Investor
Mergers and Acquisitions
Start-Ups

IPO News
IPO


Clinical - Post-Approval (Research/Post Marketing/Phase IV)
Zogenix, Inc. (ZGNX) Release: New Data Shows Zohydro® ER Reduced Pain And Improved Function In People With Chronic Pain 9/18/2014 11:17:51 AM
Janssen-Cilag International NV (JNJ) Release: Results From Head-To-Head Studies Of INVOKANA® (Canagliflozin) Versus JANUVIA (Sitagliptin) Highlight The Importance Of Weight-Change On Quality Of Life And Cost Effectiveness Of Canagliflozin Among People With Type 2 Diabetes 9/17/2014 11:21:55 AM
Vince & Associates Clinical Research Completes Enrollment Of Human Abuse Liability Study For Centanafadine For Adult ADHD 9/16/2014 12:28:26 PM
Study Shows Novo Nordisk A/S (NVO)'s New Diabetes Drug Tresiba Effective And Safe For Children 9/16/2014 6:05:24 AM
Astellas Pharma Inc. (ALPMY) Release: U.S. FDA Approves New Indication For The Use Of XTANDI® (enzalutamide) Capsules For Patients With Metastatic Castration-Resistant Prostate Cancer 9/11/2014 7:16:16 AM
Teva Pharmaceutical Industries Limited (TEVA) Presents New Data Which Demonstrate Reduction Of Injection-Related Adverse Events With The Less Frequent Dosing Of Three-Times-A-Week COPAXONE® (Glatiramer Acetate Injection) 40 Mg Compared To Daily COPAXONE® 20 Mg 9/11/2014 7:59:33 AM
Novartis AG (NVS): Rate Of Brain Shrinkage Faster In Multiple Schlerosis Patients 9/10/2014 6:50:49 AM
Novaliq GmbH Announces Positive Results From Novatears® Observational Study In Mild To Moderate Evaporative Dry Eye Disease 9/10/2014 10:30:31 AM
Sanofi Pasteur (SASY.PA) Release: FDA Approves Use Of Menactra® Vaccine For Booster Immunization Against Potentially Deadly Disease 9/9/2014 7:25:31 AM
Amgen (AMGN), Servier Heart Drug Runs Into Safety Concerns In Major Clinical Study 9/3/2014 6:31:01 AM
The International Myeloma Foundation Says Newly Published Study Confirms Survival Advantage With REVLIMID® And Further Advantages With Continuous Use In Newly Diagnosed Multiple Myeloma Patients Not Eligible For Transplant 9/4/2014 10:48:32 AM
Boehringer Ingelheim Corporation Release: European Society of Cardiology Congress 2014 Hot Line Session: Favourable Effect Of Pradaxa® On Kidney Function Over Time Compared To Warfarin 9/2/2014 11:07:44 AM
Zogenix, Inc. (ZGNX) Release: Zohydro® ER Demonstrates Sustained 12-Hour Pain Relief 9/2/2014 8:26:35 AM
Vifor Pharma Release: CONFIRM-HF Study Demonstrates That Injectafer® (Ferinject®) Improves Exercise Capacity In Patients With Chronic Heart Failure 9/2/2014 8:10:20 AM
MediciNova, Inc. To Initiate Clinical Trial Of MN-166 (Ibudilast) In ALS 8/26/2014 7:16:24 AM
1234567
//-->